share_log

Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $112

Benzinga ·  Feb 29 21:09

Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $102 to $112.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment